Xtant Medical

2018 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014

Xtant Medical Announces Compliance with NYSE American

02/15/18

Reports Pro Forma Stockholders’ Equity of approximately $47.4M as of 2/15/18 Xtant has regained compliance with the NYSE American listing standards BELGRADE, Mont., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Xtant™ Medical Holdings, Inc. (NYSE America...

Read More

Xtant Medical Announces Exchange of Outstanding Convertible Notes and Closing of Private Placement

02/14/18

Exchange of $70.238M (plus interest) of convertible notes into 10,401,309 shares of common stock at $7.20 per share. $6.809M Private Placement representing 945,819 shares of common stock at $7.20 per share. BELGRADE, Mont., Feb. 14, 2018 (GLO...

Read More

Xtant Medical Announces Results of Special Meeting of Stockholders

02/13/18

Approval of the issuance of new shares of common stock, as required by the NYSE American. Approval of an amendment to its certificate of incorporation, enabling its previously announced 1:12 reverse stock split. Approval of new directors to...

Read More

Xtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible Notes

01/18/18

Conversion of $1.627M (plus interest) of convertible notes into common stock Exchange of $70.238M (plus interest) of convertible notes into common stock Upon stockholder approval, amendment of Certificate of Incorporation to effect reverse st...

Read More